"The US Food and Drug Administration (FDA) has approved Akorn Inc's phenylephrine hydrochloride ophthalmic solution (2.5% and 10%), the company has announced.
The alpha-1 adrenergic receptor agonist is commonly used by optometrists, ophtha"...
Overdosage will not ordinarily cause acute problems. If accidentally ingested, drink fluids to dilute.
OCUFEN® ophthalmic solution is contraindicated in individuals who are hypersensitive to any components of the medication.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 8/3/2012
Additional Ocufen Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.